{
    "nctId": "NCT04732455",
    "briefTitle": "Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients",
    "officialTitle": "Intravenous Lidocaine Infusion Versus Oral Duloxetine For The Prevention And Treatment Of Chemotherapy Induced Peripheral Neuropathy Among Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Change in Neuropathic pain characters and severity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer\n* at any stage,\n* Taxane chemo-protocol.\n\nExclusion Criteria:\n\n* Documented history of gloves and stock neuropathy.\n* Alcohol abuse.\n* Abnormal renal or liver function tests.\n* Allergy to local anesthetics.\n* Myocardial infarction within 6 months\n* Profound high-grade arrhythmias.\n* Patients with neurological or psychological problems.\n* Diabetes Mellitus.\n* History of previous chemotherapy treatment",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}